C12N 2760/12071
Demonstrated in vivo effect
C12N2760/12071 (Demonstrated in vivo effect) appears on 1 US grants and 3 published applications in this corpus.
Search patents in C12N- Granted patents
- 1
- Published applications
- 3
- Assignees
- 3
- Inventors
- 31
- Latest grant
- 14 Apr 2020
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 1 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Mutant of rsv f protein30 Apr 2026US 2026/0117202 A1National Vaccine and Serum Institute(Nvsi)
- Expression system and nucleic acid-based pharmaceutical composition comprising same14 Nov 2024US 2024/0374707 A1Sml Biopharm Co., Ltd.
- Ehv insertion site orf7022 Mar 2018US 2018/0080043 A1Boehringer Ingelheim Vetmedica GmbH
Most cited
By later US patents